US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

17.28

+0.26001.53%

Post-market: 17.280.00000.00%19:30 EDT

Volume:957.41K

Turnover:16.63M

Market Cap:989.46M

PE:-20.70

High:17.71

Open:17.26

Low:17.00

Close:17.02

52wk High:18.14

52wk Low:1.54

Shares:57.26M

Float Shares:41.60M

Volume Ratio:0.62

T/O Rate:2.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8347

EPS(LYR):-0.8974

ROE:-27.10%

ROA:-18.45%

PB:4.13

PE(LYR):-19.26

Loading ...

Overview Company News Filings

Climb Bio - No Serious Adverse Events or Dose Limiting Toxicities Observed for Clym116 in Phase 1 - SEC Filing

THOMSON REUTERS

Climb Bio reports initial Phase 1 safety data for CLYM116 in healthy volunteers at ERA 2026

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Climb Bio (CLYM) and TransMedics Group (TMDX)

BRIEF-Climb Bio - Files For Resale Of Up To 11.6 Million Shares Of Common Stock By Selling Stockholders

Climb Bio - Files for Resale of up to 11.6 Mln Shares of Common Stock by Selling Stockholders- SEC Filing

THOMSON REUTERS

H.C. Wainwright Sticks to Their Buy Rating for Climb Bio (CLYM)

Climb Bio presents initial Phase 1 data for CLYM116 in healthy volunteers at ERA 2026

Analysts Are Bullish on These Healthcare Stocks: Climb Bio (CLYM), ArriVent BioPharma, Inc. (AVBP)

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Climb Bio (CLYM)

Climb Bio Is Maintained at Buy by HC Wainwright & Co.

Climb Bio, Inc. : H.c. Wainwright Raises Target Price to $20 From $15

THOMSON REUTERS

Climb Bio Is Maintained at Outperform by Wedbush

Climb Bio price target raised to $17 from $15 at Wedbush

Climb Bio Q1 EPS $(0.20) Beats $(0.29) Estimate

Benzinga Earnings

Climb Bio plans multiple-dose study of budoprutug subcutaneous formulation in autoimmune patients

Climb Bio price target raised to $19 from $8 at BTIG

Wedbush Adjusts Price Target on Climb Bio to $15 From $14, Maintains Outperform Rating

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: DaVita (DVA), IQVIA Holdings (IQV) and Climb Bio (CLYM)

Climb Bio Inc : Leerink Partners Raises Target Price to $15 From $10

THOMSON REUTERS

Climb Bio Initiated at Buy by Chardan Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CLYM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLYM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":17.28,"timestamp":1787342400000,"preClose":17.02,"halted":0,"volume":957412,"hourTrading":{"tag":"盘后","latestPrice":17.28,"preClose":17.28,"latestTime":"19:30 EDT","volume":7089,"amount":122499.865,"timestamp":1787355006329,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.015276145710928411,"floatShares":41603800,"shares":57260500,"eps":-0.83475,"marketStatus":"Market Closed","change":0.26,"latestTime":"08-21 16:00:00 EDT","open":17.26,"high":17.71,"low":17,"amount":16630952.052643998,"amplitude":0.041716,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.83475,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":17.02,"preHourTrading":{"tag":"盘前","latestPrice":17.29,"preClose":17.02,"latestTime":"09:29 EDT","volume":1986,"amount":34126.264176000004,"timestamp":1787318999986,"change":0.27,"changeRate":0.015864,"amplitude":0.074618},"postHourTrading":{"tag":"盘后","latestPrice":17.28,"preClose":17.28,"latestTime":"19:30 EDT","volume":7089,"amount":122499.865,"timestamp":1787355006329,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6205729475154357,"impliedVol":1.1369,"impliedVolPercentile":0.449},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","floatShares":41603800,"roa":"-18.45%","roe":"-27.10%","lyrEps":-0.897422,"volumeRatio":0.6205729475154357,"shares":57260500,"dividePrice":0,"high":17.71,"amplitude":0.041716,"preClose":17.02,"low":17,"week52Low":1.54,"pbRate":"4.13","week52High":18.135,"institutionHeld":0,"latestPrice":17.28,"eps":-0.83475,"divideRate":0,"volume":957412,"delay":0,"ttmEps":-0.83475,"open":17.26,"prevYearClose":4,"prevWeekClose":16.33,"prevMonthClose":11.9,"prevQuarterClose":13.04,"fiveDayClose":16.33,"twentyDayClose":12.84,"sixtyDayClose":11.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLYM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"CLYM","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"CLYM","fiscalQuarterEnding":"2026/03","expectedEps":-0.26,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2026-03-05","symbol":"CLYM","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"CLYM","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"CLYM","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLYM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLYM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5333,"buy":0.4667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5333,"analysts":15,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLYM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLYM","date":"2026-08-21","current":-20.700809,"percent":0.00641,"low":-17.383179,"twenty":-6.686846,"median":-3.057921,"eighty":-1.239293,"high":-0.85032,"avg":-4.515202,"sd":3.962963,"marketCap":977565060},"quantilePoints":[{"date":"2024-10-04","current":-5.327624,"twenty":-5.327624,"median":-5.327624,"eighty":-5.327624,"marketCap":342006831},{"date":"2024-10-11","current":-5.369409,"twenty":-5.463426,"median":-5.390302,"eighty":-5.369409,"marketCap":344689237},{"date":"2024-10-18","current":-5.076912,"twenty":-5.494765,"median":-5.390302,"eighty":-5.327624,"marketCap":325912392},{"date":"2024-10-25","current":-4.85754,"twenty":-5.463426,"median":-5.327624,"eighty":-5.014234,"marketCap":311829757},{"date":"2024-10-31","current":-4.094958,"twenty":-5.404927,"median":-5.238831,"eighty":-4.776059,"marketCap":262875838},{"date":"2024-11-08","current":-3.677105,"twenty":-5.390302,"median":-5.014234,"eighty":-4.074065,"marketCap":236051773},{"date":"2024-11-15","current":-3.107258,"twenty":-5.373588,"median":-4.888879,"eighty":-3.806639,"marketCap":214779913},{"date":"2024-11-22","current":-2.917613,"twenty":-5.335981,"median":-4.293438,"eighty":-3.619939,"marketCap":201671280},{"date":"2024-11-29","current":-3.141297,"twenty":-5.327624,"median":-4.220314,"eighty":-3.127681,"marketCap":217132744},{"date":"2024-12-06","current":-2.830085,"twenty":-5.277482,"median":-3.974826,"eighty":-3.040153,"marketCap":195621141},{"date":"2024-12-13","current":-2.742557,"twenty":-5.237786,"median":-3.781569,"eighty":-2.995417,"marketCap":189571003},{"date":"2024-12-20","current":-1.896449,"twenty":-5.13959,"median":-3.671882,"eighty":-2.96235,"marketCap":131086332},{"date":"2024-12-27","current":-2.207661,"twenty":-5.051841,"median":-3.301766,"eighty":-2.921503,"marketCap":152597935},{"date":"2025-01-03","current":-2.013153,"twenty":-5.003788,"median":-3.151022,"eighty":-2.57139,"marketCap":139153183},{"date":"2025-01-10","current":-1.818646,"twenty":-4.962003,"median":-3.124277,"eighty":-2.236837,"marketCap":125708431},{"date":"2025-01-17","current":-1.954801,"twenty":-4.920218,"median":-3.063494,"eighty":-2.032604,"marketCap":135119757},{"date":"2025-01-24","current":-1.770019,"twenty":-4.870076,"median":-3.005142,"eighty":-1.952856,"marketCap":122347243},{"date":"2025-01-31","current":-1.876998,"twenty":-4.531614,"median":-2.995417,"eighty":-1.91979,"marketCap":129741856},{"date":"2025-02-07","current":-1.701941,"twenty":-4.324777,"median":-2.96624,"eighty":-1.892559,"marketCap":117641580},{"date":"2025-02-14","current":-1.546335,"twenty":-4.251653,"median":-2.932201,"eighty":-1.865328,"marketCap":106885778},{"date":"2025-02-21","current":-1.400454,"twenty":-4.228671,"median":-2.873849,"eighty":-1.840042,"marketCap":96802214},{"date":"2025-02-28","current":-1.351828,"twenty":-4.1451,"median":-2.528598,"eighty":-1.818646,"marketCap":93441026},{"date":"2025-03-07","current":-1.429631,"twenty":-4.03228,"median":-2.256288,"eighty":-1.756403,"marketCap":98818927},{"date":"2025-03-14","current":-1.293475,"twenty":-3.971692,"median":-2.18821,"eighty":-1.542445,"marketCap":89407600},{"date":"2025-03-21","current":-1.244848,"twenty":-3.871407,"median":-2.022879,"eighty":-1.474368,"marketCap":86046412},{"date":"2025-03-28","current":-1.159638,"twenty":-3.794104,"median":-1.954801,"eighty":-1.429631,"marketCap":85693751},{"date":"2025-04-04","current":-1.050066,"twenty":-3.724618,"median":-1.940213,"eighty":-1.381004,"marketCap":77596704},{"date":"2025-04-11","current":-1.059197,"twenty":-3.680923,"median":-1.925625,"eighty":-1.357663,"marketCap":78271458},{"date":"2025-04-17","current":-1.150507,"twenty":-3.672927,"median":-1.896449,"eighty":-1.324596,"marketCap":85018997},{"date":"2025-04-25","current":-1.187031,"twenty":-3.573219,"median":-1.876998,"eighty":-1.28764,"marketCap":87718013},{"date":"2025-05-02","current":-1.150507,"twenty":-3.328025,"median":-1.867273,"eighty":-1.252628,"marketCap":85018997},{"date":"2025-05-09","current":-1.088206,"twenty":-3.166583,"median":-1.847822,"eighty":-1.218825,"marketCap":80415162},{"date":"2025-05-16","current":-0.872124,"twenty":-3.152968,"median":-1.818646,"eighty":-1.187031,"marketCap":81090920},{"date":"2025-05-23","current":-0.872124,"twenty":-3.141297,"median":-1.818646,"eighty":-1.164325,"marketCap":81090920},{"date":"2025-05-30","current":-0.886659,"twenty":-3.134489,"median":-1.784607,"eighty":-1.159638,"marketCap":82442435},{"date":"2025-06-06","current":-0.901194,"twenty":-3.10434,"median":-1.750568,"eighty":-1.150507,"marketCap":83793951},{"date":"2025-06-13","current":-0.930265,"twenty":-3.086835,"median":-1.590099,"eighty":-1.125277,"marketCap":86496981},{"date":"2025-06-20","current":-0.893927,"twenty":-3.063494,"median":-1.522022,"eighty":-1.106495,"marketCap":83118193},{"date":"2025-06-27","current":-0.91573,"twenty":-3.014867,"median":-1.478258,"eighty":-1.095721,"marketCap":85145466},{"date":"2025-07-03","current":-0.930265,"twenty":-3.007087,"median":-1.439356,"eighty":-1.066502,"marketCap":86496981},{"date":"2025-07-11","current":-0.981139,"twenty":-2.997362,"median":-1.429631,"eighty":-1.007303,"marketCap":91227285},{"date":"2025-07-18","current":-1.061084,"twenty":-2.995417,"median":-1.400454,"eighty":-0.995674,"marketCap":98660619},{"date":"2025-07-25","current":-1.075619,"twenty":-2.995417,"median":-1.376141,"eighty":-1.007303,"marketCap":100012135},{"date":"2025-08-01","current":-1.017477,"twenty":-2.979856,"median":-1.361553,"eighty":-1.016024,"marketCap":94606073},{"date":"2025-08-08","current":-1.220973,"twenty":-2.968185,"median":-1.346965,"eighty":-1.017477,"marketCap":113527288},{"date":"2025-08-15","current":-2.492713,"twenty":-2.95846,"median":-1.351828,"eighty":-1.023291,"marketCap":116554252},{"date":"2025-08-22","current":-3.173861,"twenty":-2.979856,"median":-1.366416,"eighty":-1.024745,"marketCap":148403379},{"date":"2025-08-29","current":-3.333278,"twenty":-3.007087,"median":-1.381004,"eighty":-1.030392,"marketCap":155857430},{"date":"2025-09-05","current":-3.376756,"twenty":-3.075164,"median":-1.400454,"eighty":-1.031929,"marketCap":157890353},{"date":"2025-09-12","current":-3.478204,"twenty":-3.149077,"median":-1.429631,"eighty":-1.042845,"marketCap":162633840},{"date":"2025-09-19","current":-3.246323,"twenty":-3.164638,"median":-1.439356,"eighty":-1.052316,"marketCap":151791584},{"date":"2025-09-26","current":-3.043428,"twenty":-3.197049,"median":-1.483121,"eighty":-1.053816,"marketCap":142304610},{"date":"2025-10-03","current":-2.956473,"twenty":-3.173861,"median":-1.53661,"eighty":-1.057045,"marketCap":138238764},{"date":"2025-10-10","current":-2.739085,"twenty":-3.171828,"median":-1.667902,"eighty":-1.060329,"marketCap":128074149},{"date":"2025-10-17","current":-2.82604,"twenty":-3.164638,"median":-1.760293,"eighty":-1.06543,"marketCap":132139995},{"date":"2025-10-24","current":-2.88401,"twenty":-3.171828,"median":-1.808921,"eighty":-1.072703,"marketCap":134850559},{"date":"2025-10-31","current":-2.88401,"twenty":-3.164638,"median":-1.818646,"eighty":-1.075619,"marketCap":134850559},{"date":"2025-11-07","current":-2.603692,"twenty":-3.149077,"median":-1.838097,"eighty":-1.083171,"marketCap":132139995},{"date":"2025-11-14","current":-2.512362,"twenty":-3.141297,"median":-1.857547,"eighty":-1.088206,"marketCap":127504893},{"date":"2025-11-21","current":-2.324271,"twenty":-3.120874,"median":-1.876998,"eighty":-1.092715,"marketCap":117959072},{"date":"2025-11-28","current":-2.539232,"twenty":-3.101423,"median":-1.886723,"eighty":-1.096373,"marketCap":128868582},{"date":"2025-12-05","current":-2.324271,"twenty":-3.090364,"median":-1.896449,"eighty":-1.097379,"marketCap":117959072},{"date":"2025-12-12","current":-3.090071,"twenty":-3.088805,"median":-1.930487,"eighty":-1.097422,"marketCap":156824200},{"date":"2025-12-19","current":-5.88457,"twenty":-3.141297,"median":-1.945076,"eighty":-1.098568,"marketCap":298647825},{"date":"2025-12-26","current":-4.562679,"twenty":-3.173183,"median":-1.969389,"eighty":-1.101167,"marketCap":231560509},{"date":"2026-01-02","current":-3.763034,"twenty":-3.231831,"median":-2.032604,"eighty":-1.10469,"marketCap":190977740},{"date":"2026-01-09","current":-4.308674,"twenty":-3.260816,"median":-2.195782,"eighty":-1.104852,"marketCap":218669512},{"date":"2026-01-16","current":-3.54666,"twenty":-3.333278,"median":-2.236837,"eighty":-1.106495,"marketCap":179996519},{"date":"2026-01-23","current":-4.619124,"twenty":-3.365162,"median":-2.283966,"eighty":-1.112485,"marketCap":234425175},{"date":"2026-01-30","current":-4.496826,"twenty":-3.449218,"median":-2.324271,"eighty":-1.121288,"marketCap":228218399},{"date":"2026-02-06","current":-4.374527,"twenty":-3.488132,"median":-2.337706,"eighty":-1.123114,"marketCap":222011622},{"date":"2026-02-13","current":-4.957797,"twenty":-3.580579,"median":-2.363428,"eighty":-1.131766,"marketCap":251613172},{"date":"2026-02-20","current":-5.305878,"twenty":-3.670837,"median":-2.397337,"eighty":-1.138397,"marketCap":269278613},{"date":"2026-02-27","current":-6.942798,"twenty":-3.770448,"median":-2.418317,"eighty":-1.146855,"marketCap":352353930},{"date":"2026-03-06","current":-5.895163,"twenty":-3.911674,"median":-2.457761,"eighty":-1.150507,"marketCap":352831374},{"date":"2026-03-13","current":-5.794315,"twenty":-4.006508,"median":-2.512362,"eighty":-1.150507,"marketCap":346795534},{"date":"2026-03-20","current":-5.570843,"twenty":-4.127762,"median":-2.533915,"eighty":-1.150507,"marketCap":333420500},{"date":"2026-03-27","current":-5.674598,"twenty":-4.262099,"median":-2.552667,"eighty":-1.150507,"marketCap":339630337},{"date":"2026-04-02","current":-5.546899,"twenty":-4.40275,"median":-2.552667,"eighty":-1.154159,"marketCap":331987461},{"date":"2026-04-10","current":-6.424826,"twenty":-4.493063,"median":-2.591615,"eighty":-1.159638,"marketCap":384532239},{"date":"2026-04-17","current":-7.039457,"twenty":-4.68874,"median":-2.608653,"eighty":-1.159638,"marketCap":421318549},{"date":"2026-04-24","current":-7.199082,"twenty":-4.833617,"median":-2.724593,"eighty":-1.160328,"marketCap":430872257},{"date":"2026-05-01","current":-7.087345,"twenty":-4.902724,"median":-2.742557,"eighty":-1.16195,"marketCap":424184661},{"date":"2026-05-08","current":-9.505662,"twenty":-5.051841,"median":-2.788531,"eighty":-1.165206,"marketCap":568923347},{"date":"2026-05-15","current":-10.251886,"twenty":-5.174172,"median":-2.811548,"eighty":-1.168769,"marketCap":541217592},{"date":"2026-05-22","current":-9.871852,"twenty":-5.232411,"median":-2.842555,"eighty":-1.168769,"marketCap":521154804},{"date":"2026-05-29","current":-10.260935,"twenty":-5.270935,"median":-2.876764,"eighty":-1.172421,"marketCap":541695277},{"date":"2026-06-05","current":-9.871852,"twenty":-5.327624,"median":-2.88401,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-12","current":-9.871852,"twenty":-5.377318,"median":-2.898503,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-18","current":-12.299862,"twenty":-5.428177,"median":-2.912995,"eighty":-1.187031,"marketCap":649334330},{"date":"2026-06-26","current":-13.731592,"twenty":-5.484622,"median":-2.927339,"eighty":-1.196162,"marketCap":724918221},{"date":"2026-07-02","current":-14.414918,"twenty":-5.570843,"median":-2.937064,"eighty":-1.198568,"marketCap":760992350},{"date":"2026-07-10","current":-14.989779,"twenty":-5.662848,"median":-2.956494,"eighty":-1.212372,"marketCap":791340427},{"date":"2026-07-17","current":-13.644821,"twenty":-5.682623,"median":-2.970966,"eighty":-1.219913,"marketCap":720337379},{"date":"2026-07-24","current":-13.840057,"twenty":-5.734417,"median":-2.990438,"eighty":-1.223039,"marketCap":730644273},{"date":"2026-07-31","current":-13.102499,"twenty":-5.816662,"median":-2.995417,"eighty":-1.223555,"marketCap":691707117},{"date":"2026-08-07","current":-13.912299,"twenty":-5.930387,"median":-3.014443,"eighty":-1.230727,"marketCap":801682322},{"date":"2026-08-14","current":-14.682008,"twenty":-6.54289,"median":-3.029148,"eighty":-1.235508,"marketCap":846036036},{"date":"2026-08-21","current":-16.964547,"twenty":-6.686846,"median":-3.057921,"eighty":-1.239293,"marketCap":977565060}],"updateTime":1787498806852},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLYM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641117806","title":"Climb Bio - No Serious Adverse Events or Dose Limiting Toxicities Observed for Clym116 in Phase 1 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641117806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641117806?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:14","pubTimestamp":1780658080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D08X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641112286","title":"Climb Bio reports initial Phase 1 safety data for CLYM116 in healthy volunteers at ERA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641112286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641112286?lang=en_us&edition=fundamental","pubTime":"2026-06-05 19:00","pubTimestamp":1780657231,"startTime":"0","endTime":"0","summary":"Climb Bio presented initial Phase 1 safety data for CLYM116 at the European Renal Association Congress 2026.Early results showed the drug was generally well tolerated in healthy volunteers, supporting continued development in IgA nephropathy.Additional Phase 1 pharmacokinetic and pharmacodynamic data are scheduled for presentation at a late-summer R&D Spotlight event.Partner Beijing Mabworks expects to start dosing IgA nephropathy patients in a Phase 2 study in Q3 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDLb4S4Mr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","BK4139","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","BK4539","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014039.USD","CLYM","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640481479","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Climb Bio (CLYM) and TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640481479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640481479?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:11","pubTimestamp":1780402267,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kymera Therapeutics (KYMR), Climb Bio (CLYM) and T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-climb-bio-clym-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-climb-bio-clym-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","XLV","BK4581","LU2324357040.USD","LU2065731478.USD","TMDX","CLYM","BK4082","LU0029874061.USD","BK4585","BK4588","XBI","BK4139","BK4137","HCSG","LU0128526141.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639714672","title":"BRIEF-Climb Bio - Files For Resale Of Up To 11.6 Million Shares Of Common Stock By Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2639714672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639714672?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:11","pubTimestamp":1780085462,"startTime":"0","endTime":"0","summary":"BRIEF-Climb Bio - Files For Resale Of Up To 11.6 Million Shares Of Common Stock By Selling StockholdersMay 29  - Climb Bio Inc CLYM.O:CLIMB BIO - FILES FOR RESALE OF UP TO 11.6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS- SEC FILINGFurther company coverage: CLYM.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4260X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639567221","title":"Climb Bio - Files for Resale of up to 11.6 Mln Shares of Common Stock by Selling Stockholders- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2639567221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639567221?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:07","pubTimestamp":1780085258,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4260X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638445175","title":"H.C. Wainwright Sticks to Their Buy Rating for Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638445175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638445175?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:55","pubTimestamp":1779818112,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright maintained a Buy rating on Climb Bio, with a price target of $20.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638167565","title":"Climb Bio presents initial Phase 1 data for CLYM116 in healthy volunteers at ERA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638167565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638167565?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:05","pubTimestamp":1779793535,"startTime":"0","endTime":"0","summary":"Climb Bio flagged upcoming data presentations at the European Renal Association Congress in Glasgow on June 3-6, 2026.Initial Phase 1 safety findings for CLYM116 in healthy volunteers will be presented on June 5.PK/PD modeling for CLYM116 to support development in IgA nephropathy will also be presented at the meeting.A trial-in-progress update will outline PrisMN, an ongoing Phase 2 study of budoprutug in primary membranous nephropathy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL4t6dgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636898531","title":"Analysts Are Bullish on These Healthcare Stocks: Climb Bio (CLYM), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636898531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636898531?lang=en_us&edition=fundamental","pubTime":"2026-05-20 07:10","pubTimestamp":1779232231,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Climb Bio (CLYM) and ArriVent BioPharma, Inc. (AVBP)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-climb-bio-clym-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-climb-bio-clym-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","BK4539","AVBP","LU0029874061.USD","BLSX","BK4581","CLYM","BLSG","LABU","LU0128526141.USD","BK4585","XBI","BK4112","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635441117","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635441117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635441117?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:50","pubTimestamp":1778777405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Voyager Therapeutics (VYGR) and Climb Bio (CLYM) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4539","HCSG","BK4139","CLYM","XBI","BK4581","BK4137","VYGR","LABU","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218555","title":"Climb Bio Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218555","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218555?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:57","pubTimestamp":1778583420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 06:57 ET (10:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634904862","title":"Climb Bio, Inc. : H.c. Wainwright Raises Target Price to $20 From $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2634904862","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634904862?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:41","pubTimestamp":1778582462,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nAZN4SVPK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633452348","title":"Climb Bio Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2633452348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633452348?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:57","pubTimestamp":1778248620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2026 09:57 ET (13:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633452933","title":"Climb Bio price target raised to $17 from $15 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2633452933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633452933?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:46","pubTimestamp":1778247965,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Climb Bio (CLYM) to $17 from $15 and keeps an Outperform rating on the shares. With Climb Bio recently co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-17-from-15-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-17-from-15-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128635","title":"Climb Bio Q1 EPS $(0.20) Beats $(0.29) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128635","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633128635?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:27","pubTimestamp":1778160459,"startTime":"0","endTime":"0","summary":"Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.48 percent increase over losses of $(0.31) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52366958/climb-bio-q1-eps-0-20-beats-0-29-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146512","title":"Climb Bio plans multiple-dose study of budoprutug subcutaneous formulation in autoimmune patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146512?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:17","pubTimestamp":1778152666,"startTime":"0","endTime":"0","summary":"Climb Bio highlighted completed Phase 1 results for subcutaneous budoprutug in healthy volunteers, showing B-cell depletion comparable to intravenous dosing, supporting a planned multiple-dose study in autoimmune patients.Initial readouts from ongoing budoprutug trials are scheduled for 2026, led by low-dose cohort data in immune thrombocytopenia expected in June, followed by early primary membranous nephropathy signals in Q4.CLYM116 modeling and initial Phase 1 safety data are set for presentation at ERA 2026 in June, with initial Phase 1 PK/PD data expected mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL4YV1b4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633217113","title":"Climb Bio price target raised to $19 from $8 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2633217113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633217113?lang=en_us&edition=fundamental","pubTime":"2026-05-07 15:48","pubTimestamp":1778140134,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Climb Bio (CLYM) to $19 from $8 and keeps a Buy rating on the shares. The company’s anti-CD19 mAb has multip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-19-from-8-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-19-from-8-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633282131","title":"Wedbush Adjusts Price Target on Climb Bio to $15 From $14, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633282131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633282131?lang=en_us&edition=fundamental","pubTime":"2026-05-06 22:17","pubTimestamp":1778077022,"startTime":"0","endTime":"0","summary":"Climb Bio (CLYM) has an average rating of buy and mean price target of $18.69, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139656","title":"Analysts Offer Insights on Healthcare Companies: DaVita (DVA), IQVIA Holdings (IQV) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633139656?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:32","pubTimestamp":1778074327,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on DaVita (DVA), IQVIA Holdings (IQV) and Climb Bio (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-davita-dva-iqvia-holdings-iqv-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-davita-dva-iqvia-holdings-iqv-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0477156953.USD","LU0648001328.SGD","BK4196","BK4530","LU1201861165.SGD","XBI","LU0130103400.USD","LU1201861249.SGD","DVA","BK4588","LABU","LU0130517989.USD","LU1989764748.USD","CLYM","BK4581","LU0477156797.USD","LU0198837287.USD","LU0980610538.SGD","BK4585","LU0130518102.USD","LU1989764664.SGD","IQV","LU1791710582.SGD","XLV","LU0130102774.USD","BK4139","LU0648000940.SGD","BK4559","LU1261432733.SGD","BK4121","BK4539","LU0528227936.USD","LU0882574055.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633972464","title":"Climb Bio Inc : Leerink Partners Raises Target Price to $15 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2633972464","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633972464?lang=en_us&edition=fundamental","pubTime":"2026-05-06 11:00","pubTimestamp":1778036407,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41I195:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633692800","title":"Climb Bio Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633692800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633692800?lang=en_us&edition=fundamental","pubTime":"2026-05-06 03:06","pubTimestamp":1778007960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 15:06 ET (19:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":104,"code":"91000000","status":"200"}]}}